Low BMI is a risk factor for CVD in hypertensive patients with diabetes, according to research presented at the ESC Congress today by Dr Takanori Nagahiro from Japan…. read more.
Study presenter Deepak Bhatt (pictured) – The anti-hyperglycemic agent saxagliptin neither increased or decreased therate of ischemic events when added to standard of care in patients with type… read more.
‘Big 4’ Journal Highlights – New England Journal of Medicine (NEJM) – by Bruce Sylvester – Research published on Aug. 7, 2013 in the New England Journal of Medicine/NEJM indicates… read more.
‘Big 4’ Journal Highlights – British Medical Journal (BMJ) – by Bruce Sylvester – Children of obese mothers are more likely to die before age 55 than children… read more.
World Health Matters by Gary Finnegan – Spain – A gene variant strongly associated with the development of type 2 diabetes appears to interact with a Mediterranean diet… read more.
EMA Highlights by Gary Finnegan – The EMA’s Committee for Medicinal Products for Human Use (CHMP) has a new member: Ivana Mikacic has been nominated by Croatia which… read more.
Some studies of at-risk populations suggest that up to half of the people tested for HIV never return to the doctor’s office to find out their test results…. read more.
Patients with diabetes who take certain types of medications to lower their blood sugar sometimes experience severe low blood sugar levels, whether or not their diabetes is poorly… read more.
by Bruce Sylvester – The combination of obesity and low vitamin D deficiency appears to cause a greater risk of insulin resistance than either factor alone, researchers reported… read more.
Breaking a sweat while working out regularly may reduce your risk of stroke, according to new research in the American Heart Association journal Stroke.
Poster 67 Elizabeth Goode elizabeth.goode@nnuh.nhs.uk. Chemotherapy is an independent risk factor for thromboembolism (TE), although current guidelines do not recommend routine use of anti-thrombin agents in this setting.
Researchers announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA® (sitagliptin) 100 mg once-daily achieved similar blood… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
